- Home
- BRX vs CORT Comparison
BRX vs CORT Comparison
Compare BRX & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRX
- CORT
- Stock Information
- Founded
- BRX 2011
- CORT 1998
- Country
- BRX United States
- CORT United States
- Employees
- BRX N/A
- CORT N/A
- Industry
- BRX Real Estate Investment Trusts
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- BRX Real Estate
- CORT Health Care
- Exchange
- BRX Nasdaq
- CORT Nasdaq
- Market Cap
- BRX 8.0B
- CORT 7.1B
- IPO Year
- BRX 2013
- CORT N/A
- Fundamental
- Price
- BRX $24.79
- CORT $75.80
- Analyst Decision
- BRX Buy
- CORT Strong Buy
- Analyst Count
- BRX 13
- CORT 4
- Target Price
- BRX $30.40
- CORT $142.00
- AVG Volume (30 Days)
- BRX 2.4M
- CORT 1.2M
- Earning Date
- BRX 04-28-2025
- CORT 05-05-2025
- Dividend Yield
- BRX 4.64%
- CORT N/A
- EPS Growth
- BRX 12.84
- CORT 8.36
- EPS
- BRX 1.05
- CORT 1.14
- Revenue
- BRX $1,302,325,000.00
- CORT $685,446,000.00
- Revenue This Year
- BRX $5.68
- CORT $35.85
- Revenue Next Year
- BRX $4.42
- CORT $35.22
- P/E Ratio
- BRX $23.61
- CORT $66.36
- Revenue Growth
- BRX 3.87
- CORT 30.93
- 52 Week Low
- BRX $21.32
- CORT $27.30
- 52 Week High
- BRX $30.67
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- BRX 42.89
- CORT 58.35
- Support Level
- BRX $25.39
- CORT $68.86
- Resistance Level
- BRX $26.59
- CORT $75.50
- Average True Range (ATR)
- BRX 0.52
- CORT 3.09
- MACD
- BRX -0.02
- CORT 0.36
- Stochastic Oscillator
- BRX 0.00
- CORT 88.00
About BRX Brixmor Property Group Inc.
Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.